Sigachi Industries Ltd
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 6.49Sigachi Industries demonstrates a mixed financial profile. The company exhibits strong solvency and profitability, indicating a solid foundation and efficient operations. Growth prospects are robust, driven by impressive revenue and asset expansion. However, efficiency metrics reveal challenges in asset utilization, particularly in fixed assets and working capital management. Liquidity is reasonably managed, though operating cash flow needs attention. Financial metrics such as EPS and capital expenditure scores are relatively low, suggesting areas for improvement in shareholder value and investment strategies. Overall, while the company shows considerable promise and strong financial health in some areas, there are operational inefficiencies that need to be addressed to ensure sustained success.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsHighly Undervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio2.40
- Profitability Ratio10.00
- Efficiency Ratio3.33
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio7.46
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Health Score : 6.49Sigachi Industries demonstrates a mixed financial profile. The company exhibits strong solvency and profitability, indicating a solid foundation and efficient operations. Growth prospects are robust, driven by impressive revenue and asset expansion. However, efficiency metrics reveal challenges in asset utilization, particularly in fixed assets and working capital management. Liquidity is reasonably managed, though operating cash flow needs attention. Financial metrics such as EPS and capital expenditure scores are relatively low, suggesting areas for improvement in shareholder value and investment strategies. Overall, while the company shows considerable promise and strong financial health in some areas, there are operational inefficiencies that need to be addressed to ensure sustained success.
Overall Valuation Score
P/E RATIO (TTM)
-15.46
Industry Median
23.93
Small Cap Median
23.93
P/E RATIO
11.55
P/B RATIO
1.58
Industry Median
2.53
Small Cap Median
2.53
P/S RATIO
1.65
Industry Median
1.35
Small Cap Median
1.35
Others
PEG RATIO
0.41
EV/EBITDA RATIO
6.03
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹21.03 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Growth Score : 8.00The company demonstrates strong growth in revenue, operating profit, assets, and net income. However, the negative EPS growth indicates potential challenges in translating growth into shareholder value. The company has a good growth in revenue and operating profit. The company has to work on its EPS growth so that shareholder value can be increased and maintained.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 29.53 | 20.8 | 32.12 | 22.31 | -2.05 |
| Operating Profit Growth Rate | 35.9 | 11.32 | 30.51 | 29.87 | -46 |
| Earnings Per Share (EPS) Growth | -67.01 | -100 | 4.6 | -217.58 | |
| Asset Growth Rate | 115.79 | 30.31 | 85.56 | 21.9 | -0.59 |
| Net Income Growth Rate | 33.33 | 10 | 29.55 | 22.81 | -218.57 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Financial Score : 2.40The financial ratios present a mixed view of the company's financial health. While cash earnings per share is reasonable, adjusted earnings per share, book value per share, dividend per share, and capital expenditures all score poorly. The company needs to improve its financial ratios so that it can attract more investors.
Adjusted Earnings Per Share (Adjusted EPS)Poor
Cash Earnings Per Share (Cash EPS)WeakBook Value Per SharePoorDividend Per Share (DPS)PoorCapital Expenditures (CapEx)Poor| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 1.29 | 2.84 | 1.73 | 1.87 | 0.84 |
| Cash Earnings Per Share (Cash EPS) | 1.39 | 1.65 | 2.06 | 2.26 | -1.71 |
| Book Value Per Share | 7.35 | 8.68 | 13.03 | 15.82 | 13.74 |
| Dividend Per Share (DPS) | 0.1 | 0.1 | 0.09 | 0.11 | |
| Capital Expenditures (CapEx) | 24.3 | 100.7 | 85.2 | 43.3 | 41.2 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability Score : 10.00The company exhibits excellent profitability ratios across various metrics, indicating efficient operations and strong financial performance. The company has excellent profits and has a good financial performance. The company's operations are efficient which is resulting in good profits.
Gross Profit MarginExcellentReturn on Capital Employed (ROCE)ExcellentReturn on Equity (ROE)ExcellentReturn on Assets (ROA)ExcellentOperating MarginExcellentNet MarginExcellent| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 20 | 17.22 | 16.54 | 17.21 | 7.53 |
| Return on Capital Employed (ROCE) | 28 | 20 | 17 | 16 | 6 |
| Return on Equity (ROE) | 17.54 | 16.36 | 13.26 | 11.65 | -15.9 |
| Return on Assets (ROA) | 18.47 | 15.78 | 11.1 | 11.82 | 6.42 |
| Operating Margin | 21.2 | 19.54 | 19.3 | 20.49 | 11.3 |
| Net Margin | 16 | 14.57 | 14.29 | 14.34 | -17.36 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency Score : 3.33The efficiency ratios reveal challenges in asset utilization and working capital management. The company needs to improve its efficiency in using assets. The company has to work on its receivable days as it is taking more than 120 days to receive payments. The company's fixed assets turnover ratio is low which suggests that the company is not utilising its fixed assets in a good manner. The company needs to work on capital turnover ratio so that sales can be improved with the available capital.
Fixed Asset Turnover RatioPoor
Inventory Turnover RatioAverageReceivables Turnover RatioWeakDays Sales in Inventory RatioWeakReceivable DaysPoorCapital Turnover RatioPoor| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 4.72 | 2.48 | 1.57 | 1.32 | 1.47 |
| Inventory Turnover Ratio | 7.84 | 6.49 | 5.64 | 4.9 | 5.26 |
| Receivables Turnover Ratio | 5.21 | 4.31 | 3.47 | 2.92 | 2.34 |
| Days Sales in Inventory Ratio | 46.56 | 56.24 | 64.72 | 74.49 | 69.39 |
| Receivable Days | 70.06 | 84.69 | 105.19 | 125 | 155.98 |
| Capital Turnover Ratio | 1.09 | 1.01 | 0.82 | 0.78 | 0.91 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage Score : 10.00The company exhibits excellent coverage ratios, demonstrating a strong ability to meet its interest and dividend obligations. The company can easily pay its interest and dividends obligations because of good profits and good cash reserves.
Interest Coverage RatioExcellentEquity Dividend Coverage RatioExcellent| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 53 | 14.5 | 9.75 | 8.67 | -5.29 |
| Equity Dividend Coverage Ratio | 12.5 | 16.67 | 20 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Solvency Score : 10.00The company exhibits strong solvency, indicating a solid financial structure and low risk of financial distress. All metrics within the solvency ratio category reflect excellent performance. The company has very less dependancy on debt and is well covered by its assets. The company has a healthy balance sheet because of low debt.
Debt RatioExcellentDebt to Equity RatioExcellentEquity RatioExcellentDebt To Asset RatioExcellent| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.01 | 0.1 | 0.12 | 0.04 | 0.01 |
| Debt to Equity Ratio | 0.01 | 0.11 | 0.14 | 0.04 | 0.01 |
| Equity Ratio | 0.99 | 0.9 | 0.88 | 0.96 | 0.99 |
| Debt To Asset Ratio | 0.01 | 0.08 | 0.09 | 0.03 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity Score : 7.46The company's liquidity position indicates a mixed performance. The quick ratio suggests a good ability to meet short-term obligations with its most liquid assets. However, the cash ratio and operating cash flow ratio reveal potential challenges in generating sufficient cash from operations to cover immediate liabilities. The current ratio indicates a satisfactory ability to cover current liabilities with current assets. The company has sufficient liquid assets to handle its short term obligations. The cash ratio is the concerning factor as it is very low and needs to be improved.
Current RatioGoodQuick RatioExcellentCash RatioAverageOperating Cash Flow RatioWeak| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.93 | 2.84 | 1.67 | 2.11 | 1.53 |
| Quick Ratio | 3.4 | 2.22 | 1.32 | 1.69 | 1.3 |
| Cash Ratio | 1.21 | 0.43 | 0.28 | 0.33 | 0.08 |
| Operating Cash Flow Ratio | 0.11 | 0.38 | 0.06 | 0.12 | 0.01 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 33.01 | Overvalued | 58.00 | 6.42 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 77.37 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 4 | Windlas Biotech Ltd | 7.52 | 25.92 | Neutral | 105.00 | 32.19 | 66.00 |
| 5 | Lincoln Pharmaceuticals Ltd | 7.31 | 14.01 | Neutral | 98.00 | 43.88 | 88.00 |
| 6 | NGL Fine Chem Ltd | 6.98 | 39.22 | Overvalued | 73.00 | 67.39 | 48.00 |
| 7 | Syncom Formulations (India) Ltd | 6.92 | 17.27 | Undervalued | 77.00 | 0.81 | 76.00 |
| 8 | Kilitch Drugs (India) Ltd | 6.61 | 21.54 | Neutral | 37.00 | 9.27 | 30.00 |
| 9 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 10 | Hester Biosciences Ltd | 6.54 | 31.74 | Neutral | 87.00 | 61.24 | 57.00 |
| 11 | Sigachi Industries Ltd | 6.49 | 11.55 | Highly Undervalued | 54.00 | -2.08 | -83.00 |
| 12 | Sakar Healthcare Ltd | 5.81 | 58.66 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.48 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | Ind-Swift Laboratories Ltd | 4.95 | 39.28 | Neutral | 45.00 | 4.89 | 41.00 |
| 15 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 16 | Wanbury Ltd | 4.65 | 28.62 | Neutral | 88.00 | 18.93 | 43.00 |
| 17 | Solara Active Pharma Sciences Ltd | 4.34 | -274.68 | Neutral | 187.00 | -1.50 | -7.00 |
Balanced ManagementThe management of Sigachi Industries shows a mixed performance profile. Revenue growth is strong, but profitability metrics show variability. Capital efficiency is reasonable, as indicated by ROCE and ROE. However, there's a concerning rise in debt and an extended cash conversion cycle. Promoter holding has decreased. These factors collectively suggest a need for more consistent financial management and strategic capital allocation.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Revenue Expansion | 22.38% | Strong Sales Growth |
| Profitability | 22% | Sustainable Profit Growth | |
| CONS | Promoter Confidence | 44.14% | Decreasing Promoter Holding |
| Financial Leverage | ₹ 121 Cr. | Increasing Debt Levels |
Financial Performance & GrowthAverageCapital Efficiency & ReturnsAverageFinancial Health & PrudenceWeakShareholding & Ownership StructureAverageFinancial Performance & Growth
While Sigachi Industries has demonstrated robust revenue growth, its profit growth and margins present a mixed picture. The compounded sales growth remains strong across different periods, but profit growth shows some inconsistency. The OPM % fluctuates, indicating variations in operational efficiency. Overall, the financial performance shows good revenue momentum but needs more stability in profitability.
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales (₹ Cr) | 101 | 129 | 139 | 193 | 250 | 302 | 399 | 488 |
| Sales Growth (%) | - | 28.06 | 7.81 | 38.62 | 29.85 | 20.68 | 32.08 | 22.38 |
| OPM (%) | 12 | 20 | 18 | 20 | 21 | 19 | 19 | 20 |
Capital Efficiency & Returns
Sigachi Industries exhibits moderate capital efficiency. While the Return on Equity (ROE) and Return on Capital Employed (ROCE) are reasonable, there has been a decline in recent years. This suggests that while the company generates returns on shareholder equity and capital employed, the efficiency is not consistently improving. The cash conversion cycle is increasing, which indicates less efficiency in working capital management that needs improvement.
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROCE (%) | 44% | 34% | 38% | 28% | 20% | 17% | 16% |
| Cash Conversion Cycle (Days) | 145 | 177 | 116 | 149 | 165 | 180 | 234 |
Financial Health & Prudence
The financial health of Sigachi Industries shows some concerning trends. The debt levels have increased significantly, as reflected in the rising borrowings. This increasing debt impacts the company's financial stability and increases financial risk. Dividend payout is inconsistent. This overall scenario indicates a need for more prudent financial management to ensure long-term sustainability.
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 30 | 25 | 30 | 21 | 35 | 68 | 151 | 121 |
| Dividend Payout (%) | 4% | 2% | 4% | 0% | 8% | 0% | 6% | 0% |
Shareholding & Ownership Structure
The shareholding pattern of Sigachi Industries indicates a moderate level of stability but with some negative trends. Promoter holding has decreased over the recent quarters, which might raise concerns about promoter confidence in the company's future. Institutional holding by FIIs and DIIs is fluctuating. The increase in the number of shareholders suggests growing public interest, but the decreasing promoter holding and inconsistent institutional interest need monitoring.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 48.48 | 48.49 | 45.43 | 44.14 |
| FIIs (%) | 0.23 | 0.09 | 2.06 | 0.08 |
| DIIs (%) | 2.92 | 0.00 | 0.00 | 0.00 |
Balanced RiskThe risk assessment for Sigachi Industries reveals a mixed picture. While there are no immediate red flags in accounting quality, the increasing debt levels and extended cash conversion cycle pose financial risks. The decrease in promoter holding also adds to the risk profile. Overall, the company exhibits moderate risk, requiring careful monitoring of financial health.
Accounting quality red flagsGoodAccounting quality red flags
Continuous monitoring of financial statements is essential to ensure ongoing compliance and transparency.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe